Sildenafil citrate, sold as Viagra, Revatio and under various other trade names, is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). It was originally discovered by Pfizer scientists Andrew Bell, David Brown, and Nicholas Terrett. It acts by inhibiting cGMP-specific phosphodiesterase type 5 (PDE5), an enzyme that promotes degradation of cGMP, which regulates blood flow in the penis. Since becoming available in 1998, sildenafil has been the prime treatment for erectile dysfunction; its primary competitors on the market are tadalafil (Cialis) and vardenafil (Levitra).
Access Full Report With TOC: http://www.orbisresearch.com/reports/index/global-sildenafil-citrate-cas-171599-83-0-market-outlook-2016-2021
This report provides detailed analysis of worldwide markets for Sildenafil Citrate (CAS 171599-83-0) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Sildenafil Citrate (CAS 171599-83-0) market and further lays out an analysis of the factors influencing the supply/demand for Sildenafil Citrate (CAS 171599-83-0), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Sildenafil Citrate (CAS 171599-83-0) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Sildenafil Citrate (CAS 171599-83-0) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Sildenafil Citrate (CAS 171599-83-0) market are Pfizer (USA), Teva Group (Israel), SMS Pharmaceuticals (India), Ajanta Pharma (India), Cadila Pharmaceuticals (India), Torrent Pharmaceuticals (India), Actavis Group (India), Cipla (India), Sun Pharmaceutical (India), Alkem Laboratories (India), Apotex Pharmachem (India), Polpharma (Poland), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Sildenafil Citrate (CAS 171599-83-0) industry has been provided.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/330462
Major Parts from Table of Content:
Part 1. Exclusive Summary
Part 2. Methodology
Part 3. Introduction
Part 4. Market Landscape
Part 5. Segmentation by Products
Part 6. Segmentation by End-users
Part 7. Geographical Segmentation
Part 8. Market Forecast
Part 9. Company Profiles
Part 10. Market Dynamics
Part 11. Competitive Landscape
Part 12. Appendix
Ask for Sample report @ http://www.orbisresearch.com/contacts/request-sample/330462
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019